Cambridge Ipsen US — Cambridge, Massachusetts

Cambridge Ipsen US is a clinical research site located in Cambridge, Massachusetts, United States 02142.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Cambridge Ipsen US has participated in 1 clinical trials.

Therapeutic areas: Fibrodysplasia Ossificans Progressiva.

Sponsors: Clementia Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cambridge Ipsen US?

Cambridge Ipsen US has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cambridge Ipsen US conducted?

Cambridge Ipsen US has 1 clinical trials on record. Their work covers Fibrodysplasia Ossificans Progressiva.

Is Cambridge Ipsen US accredited by Crixeo Health?

Cambridge Ipsen US has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cambridge Ipsen US?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.